You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (9)

Journals (0)

1-9 of 9 results for capecitabine and oxaliplatin (XELOX)

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Capecitabine plus Oxaliplatin (XelOx/CapOx) Regimen for Colorectal Cancer

Retricted access

Research article

First published 2005-7

Capecitabine plus Oxaliplatin (XelOx/CapOx) Regimen for Colorectal Cancer

Parvaneh Moussavian, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Select article: Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective,Single-Center Observational Study

Open access

Research article

First published 2021

Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective,Single-Center Observational Study

Sung E. Oh, Ji Y. An, Min-Gew Choi [...]

Technology in Cancer Research & Treatment

Select article: Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis

Open access

Research article

First published 2020

Comparative efficacy and tolerability of adjuvant systemic treatments against resectable colon cancer: a network meta-analysis

Ji Cheng, Xiaoming Shuai, Jinbo Gao [...]

Therapeutic Advances in Medical Oncology

Select article: Phase II Study of Pre-Operative Radiotherapy with Capecitabine and Oxaliplatin for Rectal Cancer and Carcinoembryonic Antigen as a Predictor of Pathological Tumour Response

Free access

Research article

First published 2010-4

Phase II Study of Pre-Operative Radiotherapy with Capecitabine and Oxaliplatin for Rectal Cancer and Carcinoembryonic Antigen as a Predictor of Pathological Tumour Response

JZ Lin, ZF Zeng, XJ Wu [...]

Journal of International Medical Research

Select article: Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection

Retricted access

Case report

First published 2012-3

Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection

Peter Gilbar, Natacha Sorour

Journal of Oncology Pharmacy Practice

Select article: Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer

Retricted access

Research article

First published 2011-07

Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer

Tingsong Yang, Xiaojun Shen, Xiaojun Tang [...]

Tumori Journal

Select article: Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized,double blind,placebo-controlled,clinical trial

Retricted access

Research article

First published 2020-10

Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: A randomized,double blind,placebo-controlled,clinical trial

Nazanin Bondad, Reza Boostani, Alireza Barri [...]

Journal of Oncology Pharmacy Practice

Select article: Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study,a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC

Open access

Research article

First published 2020

Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study,a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC

Daniela Bianconi, Merima Herac, Florian Posch [...]

Therapeutic Advances in Medical Oncology

Select article: Nivolumab plus chemotherapy in metastatic gastric cancer with low combined positive score

Open access

Research article

First published 2025

Nivolumab plus chemotherapy in metastatic gastric cancer with low combined positive score

Junkyu Kim, Changgon Kim, Ji Eun Shin [...]

Therapeutic Advances in Gastroenterology

1
10 / page

Article type

Publication date

Subjects

Access